New FDI World Dental Federation care pathway promotes dentist-patient collaboration to manage partial tooth loss

FDI has launched a series of tools to offer this patient group a tailored, comprehensive approach to treatment and care. These include the Collaborative Care Continuum: The 3Cs pathway for partially dentate patients white paper, as well as guidelines designed for oral health professionals that support patient-practitioner communication and offer advice to manage patients who are partially dentate.

Even partial tooth loss affects many aspects of life and may:

• limit the enjoyment of certain foods;

• undermine self-confidence;

• lead to social isolation and affect relationships with others.

“Our work is focused on a personalized approach to managing partially dentate patients - said FDI President dr Kathryn Kell. - We know that good patient-practitioner communication is linked not only to increased patient satisfaction, but also with better adherence to treatment”.

Caring for a partially dentate patient follows a three-step process called the collaborative care continuum, or the 3Cs care pathway. This pathway includes:

• a pre-treatment and assessment phase;

• a treatment phase;

• a post-treatment and long-term care phase.

Oral health professionals should place equal importance on each of these three phases and organize their treatment and care plan along this continuum.

FDI’s work on partially dentate patients is supported by GSK. “We are excited to collaborate with FDI to improve the treatment and care for this unique group of patients - said Dr Roshan Varghese, Global Medical Affairs Director, Denture Care, GSK. - We believe that the most successful treatment relies on comprehensive patient education. A focus on long-term care and maintenance needs to become an integral part of any treatment for partially dentate patients”.

About FDI World Dental Federation

FDI is the main representative body for more than one million dentists worldwide, with a vision of leading the world to optimal oral health. Its membership comprises some 200 national member associations and specialist groups in over 130 countries. FDI is based in Geneva, Switzerland.

About GSK

GlaxoSmithKline is a science-led healthcare company with a special purpose: to help people do more, feel better, live longer. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. Our Consumer Healthcare business develops and markets an innovative portfolio of consumer preferred and expert recommended brands in the Oral Health, Pain Relief, Cold, Flu & Allergy +OTC Derm and Wellness categories.

Picture is available at AP Images (http://www.apimages.com)

CONTACT:

Charanjit Jagait

FDI Communications & Advocacy Director

phone: +41 79 796 76 13